Assessment of Erythroid and Granulocytic Hematopoietic Lineages in Patients with Non-Small-Cell Lung Carcinoma

被引：0
|
作者：
V. E. Goldberg
T. Yu. Polyakova
N. O. Popova
V. V. Vysotskaya
E. I. Simolina
Yu. V. Belevich
T. P. Tuzikova
A. V. Goldberg
V. V. Zhdanov
L. A. Miroshnichenko
E. V. Udut
E. V. Simanina
A. M. Dygai
G. N. Zyuz’kov
机构：
[1] E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine,
[2] Research Institute of Oncology,undefined
[3] Tomsk National Research Medical Center,undefined
[4] National Research Tomsk State University,undefined
来源：
Bulletin of Experimental Biology and Medicine | 2017年 / 163卷
关键词：
non-small-cell lung carcinoma; granulocytopoiesis; erythropoiesis; docetaxel; cisplatin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The toxic effects of combined cisplatin/docetaxel therapy cycles on erythroid and granulocytic hematopoietic lineages as well as their intercycle recovery were examined in patients with stage III-IV non-small-cell lung carcinoma. Responsiveness of the blood system to this therapy remained at a high level. Combined therapy pronouncedly activated the key elements of the erythroid and granulocytic hematopoietic lineages leading to accumulation of immature and mature myelokaryocytes in the bone marrow, enlargement of the medullary pool of mature neutrophils, and increase in the count of medullary erythroid and granulocytic precursor cells under conditions of their accelerated maturation.
引用
收藏
页码：469 / 474
页数：5
相关论文
共 50 条
  • [1] Assessment of Erythroid and Granulocytic Hematopoietic Lineages in Patients with Non-Small-Cell Lung Carcinoma
    Goldberg, V. E.
    Polyakova, T. Yu.
    Popova, N. O.
    Vysotskaya, V. V.
    Simolina, E. I.
    Belevich, Yu. V.
    Tuzikova, T. P.
    Goldberg, A. V.
    Zhdanov, V. V.
    Miroshnichenko, L. A.
    Udut, E. V.
    Simanina, E. V.
    Dygai, A. M.
    Zyuz'kov, G. N.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2017, 163 (04) : 469 - 474
  • [2] Pneumopericardium as a non-small-cell lung carcinoma complication
    Kubisa, Anna
    Lesinska, Anna
    Dec, Pawel
    Szewczak-Glodek, Malgorzata
    Kochanowski, Leszek
    Kubisa, Bartosz
    Feledyk, Grzegorz
    Czarnecka, Michalina
    Wojcik, Janusz
    Grodzki, Tomasz
    KARDIOCHIRURGIA I TORAKOCHIRURGIA POLSKA, 2016, 13 (03): : 257 - 259
  • [3] Undertreatment of elderly patients with non-small-cell lung cancer
    Ng, Raymond
    de Boer, Richard
    Green, Michael D.
    CLINICAL LUNG CANCER, 2005, 7 (03) : 168 - 174
  • [4] Matrix metalloproteinase pharmacogenomics in non-small-cell lung carcinoma
    Chetty, Chandramu
    Rao, Jasti S.
    Lakka, Sajani S.
    PHARMACOGENOMICS, 2011, 12 (04) : 535 - 546
  • [5] Radiochemotherapy in non-small-cell lung cancer
    Swartman, B.
    Hausmanns, J.
    Zwicker, F.
    Thomas, M.
    Herfarth, K.
    Heussel, C. P.
    MEDIZINISCHE KLINIK, 2011, 106 (03) : 212 - 217
  • [6] Current and emerging therapies for patients with advanced non-small-cell lung cancer
    Sheth, Sheetal
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2010, 67 (01) : S9 - S14
  • [7] Palonosetron for prevention of acute and delayed nausea and vomiting in non-small-cell lung carcinoma patients
    Xiaorong Dong
    Jing Huang
    Rubo Cao
    Li Liu
    Medical Oncology, 2011, 28 : 1425 - 1429
  • [8] Palonosetron for prevention of acute and delayed nausea and vomiting in non-small-cell lung carcinoma patients
    Dong, Xiaorong
    Huang, Jing
    Cao, Rubo
    Liu, Li
    MEDICAL ONCOLOGY, 2011, 28 (04) : 1425 - 1429
  • [9] Tubular nephrotoxicity induced by docetaxel in non-small-cell lung cancer patients
    Takimoto, Takayuki
    Nakabori, Tasuku
    Osa, Akio
    Morita, Satomu
    Terada, Haruko
    Oseto, Susumu
    Iwazawa, Takashi
    Abe, Kinya
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2012, 17 (04) : 395 - 398
  • [10] Treatment options for stage I non-small-cell lung carcinoma patients not suitable for lobectomy
    Forquer, Jeffrey A.
    Fakiris, Achilles J.
    McGarry, Ronald C.
    Cheung, Michael K.
    Watson, Christopher
    Harkenrider, Matthew
    Henderson, Mark A.
    Lo, Simon S.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (10) : 1443 - 1453
12345